Drug Discovery · Portland, OR · Founded 2013 · Privately Held (backing)
Operator of a cardiometabolic therapeutics platform intended to address treatment-resistant diabetes and related metabolic conditions. Sparrow Pharmaceuticals is based in Portland, OR and was founded in 2013. It was valued at $139 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $146 million across 4 recorded rounds; the latest was a $95 million Series B in Sep 2025.
PMV mark · valuation
$139.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$145.8M
Last round
Later Stage VC (Series B)
Sep 2025
Team — not yet on record
No current team members for Sparrow Pharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sparrow Pharmaceuticals with a free account
·The complete investor list: 11 names
·Watch Sparrow Pharmaceuticals: the Monday email on marks, rounds and moves
